Skip to content
Menu

GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $482.324M Est

Benzinga Newsdesk 1 hour ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.

GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.

Read at benzinga.com